Evidence Library

Showing 10 of 327 results.

Unintentional drug overdose is a leading cause of preventable death in the United States. Administering naloxone hydrochloride (naloxone) can reverse an opioid overdose and prevent these unintentional deaths. This dataset focuses on state laws that provide civil or criminal immunity to licensed healthcare providers or lay responders for opioid antagonist administration.

The historical coding for one question in Oregon was corrected. Please consult the update section at the end of the Protocol for specific details on this correction.

 

This preliminary dataset examines the laws and policies on medication assisted treatment (MAT) for opioid use disorder at state correctional facilities. The U.S. Food & Drug Administration (FDA) has approved three drugs for the treatment of opioid use disorder: buprenorphine, methadone, and naltrexone. Currently, Rhode Island is the only state that offers all three FDA-approved medications for MAT to all state inmates.  Some states provide all three medications at some of their correctional facilities.

 

Involuntary commitment laws for substance use authorize the involuntary arrest, detention, and/or treatment of an individual for substance use disorder. Building on the existing LawAtlas dataset on Laws Authorizing Involuntary Commitment for Substance Use, this dataset examines important features of involuntary commitment laws specifically focused on substance use.

 

This dataset examines statutes and regulations regarding the effect of incarceration on the state Medicaid enrollment status of Medicaid eligible people. This dataset includes questions on jurisdictions terminating Medicaid upon incarceration, suspending Medicaid upon incarceration, and how long Medicaid can be suspended. As this dataset only considers statutes and regulations, policies of correction departments and individual correctional facilities are not reflected here.

This dataset is cross-sectional, capturing currently effective law valid through August 1, 2019.

 

This dataset examines statutes that authorize the prosecution of drug-related deaths as criminal killings. Oftentimes referred to as drug induced homicide laws, these laws establish criminal liability for individuals who furnish or deliver controlled substances to another individual who dies as a result. These laws vary from state to state in how they are classified, how they are sentenced, and what elements need to be proven. This dataset highlights these differences among state drug induced homicide laws. 

 

The Problem: Tobacco use is a source of chronic and fatal illnesses for users and people exposed to tobacco smoke. Second-hand smoke exposure contributes to 41,000 deaths among non-smoking adults, and 400 infants annually. Second-hand exposure can lead to stroke, lung cancer and coronary heart disease. Children exposed to second-hand smoke are at increased risk for slowed lung growth, asthma, acute respiratory infections, middle ear infections and sudden infant death syndrome.

 

The Problem: Widespread vaccine coverage for preventable disease is an essential public health goal Healthy People 2020 Low vaccine coverage rates enable otherwise avoidable outbreaks of harmful diseases. CDC: Vaccines and Immunizations. Clinicians tend to acute and chronic conditions before preventive considerations, resulting in lack of time for vaccinations.

 
Staff •
Center for Public Health Law Research

In the United States, preemption is a legal doctrine that allows upper levels of government to restrict or even prevent a lower-level government from self-regulating. While it is most often thought of in the context of the federal government’s preemption of states, preemption is increasingly being used as a tool by states to limit cities, counties and other lower-level municipalities from legislating across a broad array of issues.

 
Scott Burris, JD •
Center for Public Health Law Research
Evan Anderson, JD •
Center for Public Health Initiatives, University of Pennsylvania
Corey Davis, JD, MSPH •
University of North Carolina at Chapel Hill
Leo Beletsky, JD, MPH •
Health in Justice Action Lab

A new Perspective article in the New England Journal of Medicine examines a recent decision by a Philadelphia judge to reject the argument that an overdose prevention site, called Safehouse, would violate the Controlled Substances Act.

The decision signals a move toward an approach to regulating drugs that minimizes both the harms of drugs and the harms caused by regulation itself – worthy goals all around, the authors write.

 

Pages